Skip to main content
. 2016 Apr 4;35(6):3143–3150. doi: 10.3892/or.2016.4732

Figure 3.

Figure 3

Expression of TPM2α and TPM2β transcripts in various malignant and non-malignant human breast tumor cell lines. A: Southern hybridization of TPM2 cDNA amplified with TPM2, Exon 1a(+) and TPM2, exon 9d(−) primers, and probed with radio-labeled TPM2 exon 5(+) oligonucleotide probe. B: Southern hybridization of cDNA amplified with TPM2, exon 1a(+) and TPM2, exon 9a(−) and probed with radio labeled TPM2 exon 5(+) oligonucleotide probe. C: Ethidium bromide-stained RT-PCR amplified DNA of human GAPDH. Lane 1, MCF7; lane 2, MCF-10A; lane 3, HCC-1143; lane 4, HCC-1143 BL; lane 5, MDA-MB-453; lane 6, MDA-MB-468; lane 7, HCC-1806; lane 8, HCC-1187; lane 9, BT-474; lane 10, MDA-MB-157; lane 11, HCC-1419; lane 12, HCC-1419 BL; lane 13, primer control.